Yuan, Meng
Andrinopoulou, Eleni-Rosalina
Kruijshaar, Michelle E.
Lika, Aglina
Harlaar, Laurike
van der Ploeg, Ans T. http://orcid.org/0000-0002-3359-1324
Rizopoulos, Dimitris
van der Beek, Nadine A. M. E.
Funding for this research was provided by:
Sanofi Genzyme
Article History
Received: 4 May 2020
Accepted: 21 July 2020
First Online: 3 September 2020
Ethics approval and consent to participate
: All studies in this paper were approved by the ethics committee of the Erasmus MC University Medical Center and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from all participants prior to their inclusion.
: Not applicable.
: A. van der Ploeg received funding for research, clinical trials and as an advisor from various industries working on ERT or next-generation therapies in the field of Pompe disease, other lysosomal storage diseases, and neuromuscular disorders under agreements with Erasmus MC University Medical Center and the relevant industry. N. van der Beek received funding for research and as advisor from various industries working on ERT or next-generation therapies in the field of Pompe disease under agreements with Erasmus MC University Medical Center and the relevant industry. The other authors declare that they have no conflict of interest.